At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 ...
A pharmacist-led clinic achieved a 94.3% success rate in venetoclax ramp-up for patients with CLL, minimizing serious TLS incidents. Pharmacists independently managed TLS prophylaxis and drug ...
Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback